Home Camurus

Camurus

In operation
IPO
A research-based pharmaceutical company

Basic Information

Camurus is a research-based pharmaceutical company dedicated to the development and commercialization of innovative specialty drugs, providing better treatment outcomes and quality of life for patients with serious and chronic diseases. The company develops drugs for treating severe and chronic conditions such as opioid addiction, pain, cancer, and endocrine disorders. A significant portion of its revenue comes from the North American region. Its product pipeline includes the CAM2038, CAM2029, and CAM2032 product candidates.
Camurus AB
Skåne,Sweden
15~50 people
January 01, 1991
info@camurus.com